• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

级联富马酸水合酶突变筛查可实现肾肿瘤的早期检测:一例报告

Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report.

作者信息

Chan Melanie M Y, Barnicoat Angela, Mumtaz Faiz, Aitchison Michael, Side Lucy, Brittain Helen, Bates Alan W H, Gale Daniel P

机构信息

Centre for Nephrology, University College London, Royal Free Hospital, London, UK.

Northeast Thames Regional Genetics Service, Great Ormond Street Hospital for Children, London, UK.

出版信息

BMC Med Genet. 2017 Jul 26;18(1):79. doi: 10.1186/s12881-017-0436-1.

DOI:10.1186/s12881-017-0436-1
PMID:28747166
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5530463/
Abstract

BACKGROUND

Fumarate hydratase (FH) deficiency is a rare autosomal recessive disorder which results in a major defect in cellular metabolism. It presents in infancy with progressive encephalopathy, hypotonia, seizures and failure to thrive and is often fatal in childhood. It is caused by mutations in the FH gene (1q42.1) that result in deficiency of the citric acid cycle enzyme fumarate hydratase, resulting in accumulation of fumaric acid. Heterozygous germline mutations in the FH gene predispose to an aggressive autosomal dominant inherited early-onset kidney cancer syndrome: hereditary leiomyomatosis and renal cell cancer (HLRCC).

CASE PRESENTATION

Cascade FH mutation screening enabled the early diagnosis of a renal tumour in an asymptomatic parent of a child with fumarate hydratase deficiency, resulting in timely and possibly life-saving treatment.

CONCLUSION

While the theoretical risk of kidney cancer in parents of children with recessive fumarate hydratase deficiency is well recognized, to our knowledge this is the first report of a kidney tumour being detected in a parent by screening performed for this indication. This underscores the importance of offering lifelong kidney surveillance to such parents and other heterozygous relatives of children born with fumarate hydratase deficiency.

摘要

背景

延胡索酸水合酶(FH)缺乏症是一种罕见的常染色体隐性疾病,会导致细胞代谢出现重大缺陷。其在婴儿期表现为进行性脑病、肌张力减退、癫痫发作和生长发育迟缓,常在儿童期致命。它由FH基因(1q42.1)突变引起,导致柠檬酸循环酶延胡索酸水合酶缺乏,从而致使富马酸积累。FH基因的杂合种系突变易引发侵袭性常染色体显性遗传的早发性肾癌综合征:遗传性平滑肌瘤病和肾细胞癌(HLRCC)。

病例报告

通过级联FH突变筛查,在一名患有延胡索酸水合酶缺乏症儿童的无症状父母中早期诊断出肾肿瘤,从而实现了及时且可能挽救生命的治疗。

结论

虽然隐性延胡索酸水合酶缺乏症患儿父母患肾癌的理论风险已得到充分认识,但据我们所知,这是首次通过针对该指征进行的筛查在父母中检测到肾肿瘤的报告。这凸显了为这些父母以及出生时患有延胡索酸水合酶缺乏症儿童的其他杂合亲属提供终身肾脏监测的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5264/5530463/ac71ec6b3611/12881_2017_436_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5264/5530463/a2956662608f/12881_2017_436_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5264/5530463/ac71ec6b3611/12881_2017_436_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5264/5530463/a2956662608f/12881_2017_436_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5264/5530463/ac71ec6b3611/12881_2017_436_Fig2_HTML.jpg

相似文献

1
Cascade Fumarate Hydratase mutation screening allows early detection of kidney tumour: a case report.级联富马酸水合酶突变筛查可实现肾肿瘤的早期检测:一例报告
BMC Med Genet. 2017 Jul 26;18(1):79. doi: 10.1186/s12881-017-0436-1.
2
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.延胡索酸水合酶缺陷型肾细胞癌与延胡索酸水合酶突变及遗传性平滑肌瘤病和肾细胞癌综合征密切相关。
Am J Surg Pathol. 2016 Jul;40(7):865-75. doi: 10.1097/PAS.0000000000000617.
3
Mild clinical presentation and prolonged survival of a patient with fumarase deficiency due to the combination of a known and a novel mutation in FH gene.由于 FH 基因中已知和新突变的组合,导致一名富马酸酶缺乏症患者的临床表现较轻且生存时间延长。
Gene. 2013 Jul 25;524(2):403-6. doi: 10.1016/j.gene.2013.03.026. Epub 2013 Apr 20.
4
Fumarase Deficiency: A Case With a New Pathogenic Mutation and a Review of the Literature.延胡索酸酶缺乏症:一例新的致病性突变病例及文献复习。
J Child Neurol. 2021 Mar;36(4):310-323. doi: 10.1177/0883073820962931. Epub 2020 Oct 14.
5
Fumarate hydratase (FH) deficiency in uterine leiomyomas: recognition by histological features versus blind immunoscreening.平滑肌肿瘤中琥珀酸脱氢酶(FH)缺陷的组织学特征与盲目免疫筛选的对比研究。
Virchows Arch. 2018 May;472(5):789-796. doi: 10.1007/s00428-018-2292-6. Epub 2018 Jan 13.
6
Fumarate Hydratase-Deficient Leiomyoma of the Uterine Corpus: Comparative Morphologic Analysis of Protein-Deficient Tumors With and Without Pathogenic Germline Fumarate Hydratase Gene Mutations.乏琥珀酸氢酶的子宫体平滑肌瘤:伴有和不伴有致病性种系琥珀酸氢酶基因突变的蛋白缺乏性肿瘤的比较形态学分析。
Int J Surg Pathol. 2024 Apr;32(2):340-355. doi: 10.1177/10668969231180285. Epub 2023 Jun 13.
7
Germline Whole-Gene Deletion of FH Diagnosed from Tumor Profiling.胚系 FH 全基因缺失通过肿瘤分析诊断。
Int J Mol Sci. 2021 Jul 26;22(15):7962. doi: 10.3390/ijms22157962.
8
Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency.多发性皮肤和子宫平滑肌瘤、遗传性平滑肌瘤病和肾癌中FH突变以及富马酸水合酶缺乏症的遗传学和功能分析。
Hum Mol Genet. 2003 Jun 1;12(11):1241-52. doi: 10.1093/hmg/ddg148.
9
The FH mutation database: an online database of fumarate hydratase mutations involved in the MCUL (HLRCC) tumor syndrome and congenital fumarase deficiency.FH突变数据库:一个关于参与遗传性平滑肌瘤病肾癌综合征(HLRCC)和先天性延胡索酸酶缺乏症的延胡索酸水合酶突变的在线数据库。
BMC Med Genet. 2008 Mar 25;9:20. doi: 10.1186/1471-2350-9-20.
10
Aberrant succination of proteins in fumarate hydratase-deficient mice and HLRCC patients is a robust biomarker of mutation status.琥珀酰化蛋白在富马酸水合酶缺陷型小鼠和 HLRCC 患者中的异常是突变状态的一个强有力的生物标志物。
J Pathol. 2011 Sep;225(1):4-11. doi: 10.1002/path.2932. Epub 2011 Jun 1.

引用本文的文献

1
Uterine Leiomyomas with Specific Histology Features of Two Fumarate Hydratase/Succinate Dehydrogenase-Deficient Tumors: A Double Case Report.具有两种富马酸水合酶/琥珀酸脱氢酶缺陷肿瘤特定组织学特征的子宫肌瘤:双病例报告。
Medicina (Kaunas). 2024 May 17;60(5):825. doi: 10.3390/medicina60050825.
2
Unusual Cutaneous Lesions in a 53-Year-Old Female: A Potential Indicator of Underlying Renal Cell Carcinoma.一名53岁女性的罕见皮肤病变:潜在的肾细胞癌指标。
Cureus. 2023 Nov 14;15(11):e48783. doi: 10.7759/cureus.48783. eCollection 2023 Nov.
3
Phenotypic and Genetic Complexity in Pediatric Movement Disorders.

本文引用的文献

1
Tubulocystic Carcinoma of the Kidney With Poorly Differentiated Foci: A Frequent Morphologic Pattern of Fumarate Hydratase-deficient Renal Cell Carcinoma.伴有低分化灶的肾管囊性癌:富马酸水合酶缺陷型肾细胞癌的常见形态学模式
Am J Surg Pathol. 2016 Nov;40(11):1457-1472. doi: 10.1097/PAS.0000000000000719.
2
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours.《2016 年世界卫生组织泌尿系统及男性生殖器官肿瘤分类—第 A 部分:肾脏、阴茎和睾丸肿瘤》。
Eur Urol. 2016 Jul;70(1):93-105. doi: 10.1016/j.eururo.2016.02.029. Epub 2016 Feb 28.
3
Fumarate Hydratase-deficient Renal Cell Carcinoma Is Strongly Correlated With Fumarate Hydratase Mutation and Hereditary Leiomyomatosis and Renal Cell Carcinoma Syndrome.
儿童运动障碍的表型和遗传复杂性
Front Genet. 2022 Jun 1;13:829558. doi: 10.3389/fgene.2022.829558. eCollection 2022.
4
Genetic Alterations in Renal Cancers: Identification of The Mechanisms Underlying Cancer Initiation and Progression and of Therapeutic Targets.肾癌中的基因改变:确定癌症起始和进展的潜在机制以及治疗靶点。
Medicines (Basel). 2020 Jul 29;7(8):44. doi: 10.3390/medicines7080044.
5
Estimation of the carrier frequency of fumarate hydratase alterations and implications for kidney cancer risk in hereditary leiomyomatosis and renal cancer.估计琥珀酸氢酶改变的携带频率及其对遗传性平滑肌瘤病和肾癌中肾癌风险的影响。
Cancer. 2020 Aug 15;126(16):3657-3666. doi: 10.1002/cncr.32914. Epub 2020 May 15.
6
Novel FH mutation associated with multiple uterine leiomyomas in Chinese siblings.中国同胞中与多发性子宫肌瘤相关的新型 FH 突变。
Mol Genet Genomic Med. 2020 Jan;8(1):e1068. doi: 10.1002/mgg3.1068. Epub 2019 Nov 26.
7
Advances in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) research.遗传性平滑肌瘤病和肾细胞癌(HLRCC)研究进展。
Semin Cancer Biol. 2020 Apr;61:158-166. doi: 10.1016/j.semcancer.2019.10.016. Epub 2019 Nov 2.
8
Oncometabolites in renal cancer.肾细胞癌中的代谢物。
Nat Rev Nephrol. 2020 Mar;16(3):156-172. doi: 10.1038/s41581-019-0210-z. Epub 2019 Oct 21.
9
Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.晚期肾细胞癌患者中癌症易感性基因种系突变的流行率。
JAMA Oncol. 2018 Sep 1;4(9):1228-1235. doi: 10.1001/jamaoncol.2018.1986.
延胡索酸水合酶缺陷型肾细胞癌与延胡索酸水合酶突变及遗传性平滑肌瘤病和肾细胞癌综合征密切相关。
Am J Surg Pathol. 2016 Jul;40(7):865-75. doi: 10.1097/PAS.0000000000000617.
4
Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.乳头状肾细胞癌的综合分子特征分析
N Engl J Med. 2016 Jan 14;374(2):135-45. doi: 10.1056/NEJMoa1505917. Epub 2015 Nov 4.
5
Hereditary leiomyomatosis and renal cell carcinoma.遗传性平滑肌瘤病和肾细胞癌
Int J Nephrol Renovasc Dis. 2014 Jun 20;7:253-60. doi: 10.2147/IJNRD.S42097. eCollection 2014.
6
Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment.遗传性平滑肌瘤病和肾细胞癌(HLRCC):肾癌风险、监测与治疗
Fam Cancer. 2014 Dec;13(4):637-44. doi: 10.1007/s10689-014-9735-2.
7
Hereditary leiomyomatosis and renal cell carcinoma syndrome-associated renal cancer: recognition of the syndrome by pathologic features and the utility of detecting aberrant succination by immunohistochemistry.遗传性平滑肌瘤病和肾细胞癌综合征相关肾细胞癌:通过病理特征识别该综合征及免疫组织化学检测异常琥珀酰化的效用。
Am J Surg Pathol. 2014 May;38(5):627-37. doi: 10.1097/PAS.0000000000000163.
8
Hereditary kidney cancer syndromes.遗传性肾癌综合征。
Adv Chronic Kidney Dis. 2014 Jan;21(1):81-90. doi: 10.1053/j.ackd.2013.10.001.
9
10 rare tumors that warrant a genetics referral.10 种需要遗传咨询的罕见肿瘤。
Fam Cancer. 2013 Mar;12(1):1-18. doi: 10.1007/s10689-012-9584-9.
10
The emerging role of fumarate as an oncometabolite.富马酸盐作为一种致癌代谢物的新兴作用。
Front Oncol. 2012 Jul 31;2:85. doi: 10.3389/fonc.2012.00085. eCollection 2012.